| |
| |
|
| Insider
Information: |
Walsh Matthew M |
| Relationship: |
Chief Financial Officer |
| City: |
Hampton |
| State: |
NH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
379,514 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,701,342 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
379,514 |
|
|
| Total
Value |
$10,701,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 7.9%
|
25.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Catalent, Inc. |
CTLT |
EVP & Chief Financial ... |
2017-08-24 |
103,703 |
|
0 |
Premium* |
|
|
Multi Color Corp |
LABL |
Director |
2016-10-03 |
1,854 |
2015-10-01 |
0 |
Premium* |
|
|
Allergan plc |
AGN |
EVP, Chief Financial O... |
2020-05-08 |
0 |
2018-02-20 |
0 |
Premium* |
|
|
Certara, Inc. |
CERT |
|
2024-05-21 |
185,631 |
|
0 |
Premium* |
|
|
Organon & Co. |
OGN |
Chief Financial Officer |
2024-05-04 |
88,326 |
2021-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGN |
Allergan plc |
EVP, Chief Financial Officer |
• – – |
2019-02-20 |
4 |
D |
$140.33 |
$313,638 |
D/D |
(2,235) |
24,181 |
0 |
- |
|
| AGN |
Allergan plc |
EVP, Chief Financial Officer |
• – – |
2018-03-08 |
4 |
B |
$153.96 |
$153,960 |
D/D |
1,000 |
25,416 |
2.74 |
- |
|
| AGN |
Allergan plc |
EVP, Chief Financial Officer |
• – – |
2018-11-16 |
4 |
B |
$157.00 |
$157,000 |
D/D |
1,000 |
26,416 |
2.74 |
- |
|
| AGN |
Allergan plc |
EVP, Chief Financial Officer |
• – – |
2018-02-20 |
4 |
A |
$160.59 |
$3,599,785 |
D/D |
22,416 |
22,416 |
0 |
- |
|
| AGN |
Allergan plc |
EVP, Chief Financial Officer |
• – – |
2018-02-21 |
4 |
B |
$160.94 |
$321,880 |
D/D |
2,000 |
24,416 |
2.74 |
- |
|
| AGN |
Allergan plc |
EVP, Chief Financial Officer |
• – – |
2020-03-02 |
4 |
A |
$193.84 |
$2,999,868 |
D/D |
15,476 |
39,657 |
0 |
- |
|
56 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
